Impact Hub Zürich - Ioannis Tarnanas is Impact Hub Fellow on Healthy Living. frederike asael photography | Facebook
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Sabine Schumann on Twitter: "Congrats to @EITHealth innovator Ioannis Tarnanas @altoida predicting #Alzheimer disease for winning the @EITeu innovator award 👏 🏆 #InnovEIT https://t.co/8Tag4JkgBe" / Twitter
![Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease](http://ww1.prweb.com/prfiles/2021/07/26/18094062/logo-large.png)
Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease
![EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health](https://eithealth.eu/wp-content/uploads/2019/08/EIT-Health-wins-3-of-5-top-European-awards-for-innovations-to-treat-cancer-predict-Alzheimer%E2%80%99s-and-detect-stroke-risk.jpg)
EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health
![GBHI Team Receive Multiple Awards for Driving Progress in Dementia Prevention and Care | Global Brain Health Institute GBHI Team Receive Multiple Awards for Driving Progress in Dementia Prevention and Care | Global Brain Health Institute](https://www.gbhi.org/sites/default/files/images/2020-09/warren-wong-kMRMcUcO81M-unsplash.jpg)